Concepedia

Filippos Kesisoglou

FK

Statistics

Publications

65

Citations

2.9K

H-Index

33

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

AstraZeneca (United Kingdom)

National and Kapodistrian University of Athens

Roche (Switzerland)

Filippos Kesisoglou is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, bioavailability, and pharmacology.

ORCID

Publications per year

2002–2024

65

Publications

65

Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling

Yasushi Shono, Ekarat Jantratid, Niels Janssen et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2009 · 158 citations

, , +16

Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans

Yasushi Shono, Ekarat Jantratid, Filippos Kesisoglou et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2010 · 130 citations

, , +16

In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration

James Butler, Bart Hens, Maria Vertzoni et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2018 · 120 citations · Full text

, , +17

Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System

Nádia Araci Bou‐Chacra, Katherine Jasmine Curo Melo, Ivan Andrés Cordova Morales et al. · The AAPS Journal · 2017 · 106 citations · Full text

, , +17

Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report

Tycho Heimbach, Sandra Suarez‐Sharp, Maziar Kakhi et al. · The AAPS Journal · 2019 · 104 citations

, , +9

1–5 of 65